NCT00839293View on ClinicalTrials.gov

Comparison of Fenofibric Acid Bioavailability From ABT-335 Capsules

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

March 31, 2009

Conditions
Healthy
Interventions
DRUG

ABT-335

Once, see arm description for more information

Trial Locations (1)

60085

Site Reference ID/Investigator# 16862, Waukegan

Sponsors

Lead Sponsor

Abbott
All Listed Sponsors
lead

Abbott

INDUSTRY